AnPac Bio-Medical Science Co., Ltd. Gains 104%

AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ) jumped higher at $7.14, representing a gain of 104%. On Tue 24 Nov 20, ANPC:NASDAQ touched a New 2-Week Intraday High of $3.84. The stock appeared on our News Catalysts scanner on Wed 25 Nov 20 at 10:38 AM in the 'MISCELLANEOUS' category. From Tue 10 Nov 20, the stock recorded 40.00% Up Days and 18.18% Green Days

The stock spiked on Mon 02 Nov 20 at $4.29 with a volume of 19M+, and its share price has been moving sideways in recent weeks.

About AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ)

AnPac Bio-Medical Science Co Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative, patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated potential to assist physicians in cancer diagnosis, prognosis and recurrence.